These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 9061704)
1. 99Tcm-phenylene imine phenol as a potential leukocyte labelling agent. Huang WT; Lo JM; Kao CH; Wang SJ Nucl Med Commun; 1997 Jan; 18(1):66-9. PubMed ID: 9061704 [TBL] [Abstract][Full Text] [Related]
2. A comparative study of 99Tcm-d,l-HMPAO and 99Tcm-d,l-CBPAO as leukocyte-labelling agents. Tsai CS; Kao CH; Yeh SJ; Wang SJ Nucl Med Commun; 1996 Jan; 17(1):76-9. PubMed ID: 8692477 [TBL] [Abstract][Full Text] [Related]
3. A comparative study of 99Tcm-HMPAO and 99Tcm-ECD as a leukocyte labelling agent. Kao CH; Huang WT; Wang YL; Lin KS; Lo JM; Wang SJ Nucl Med Commun; 1994 Apr; 15(4):294-7. PubMed ID: 8072744 [TBL] [Abstract][Full Text] [Related]
4. A study of the behaviour of cobalt chloride during the labelling of leukocytes with 99Tcm-HMPAO stabilised in vitro by the addition of cobalt chloride solution. Prangere T; Bowden AD; Beauchat V; Caulier MT; Ziegels P; Huglo D; Pickett RD; Steinling M Nucl Med Commun; 1997 Mar; 18(3):258-61. PubMed ID: 9106780 [TBL] [Abstract][Full Text] [Related]
5. A high-efficiency, rapid and multi-dose procedure for white blood cell labelling with 99Tcm-HMPAO. Ozker K; Collier BD; Hellman RS; Isitman AT; Krasnow AZ; Uzum F; Steffel FS Nucl Med Commun; 1996 Apr; 17(4):342-5. PubMed ID: 8786871 [TBL] [Abstract][Full Text] [Related]
6. In vitro evaluation of white blood cell labelling with 99Tcm radiopharmaceuticals. Segall GM; Lang EV; Chaovapong W Nucl Med Commun; 1994 Oct; 15(10):845-9. PubMed ID: 7838449 [TBL] [Abstract][Full Text] [Related]
7. Radiolabelled mixed leukocytes and pure granulocytes with stabilized 99Tcm-exametazime. Hung JC; Chowdhury S; Mahoney DW; Mullan BP Nucl Med Commun; 1998 Oct; 19(10):981-7. PubMed ID: 10234678 [TBL] [Abstract][Full Text] [Related]
8. 99Tcm-HMPAO labelled leucocytes: comparison with 111In-tropolonate labelled granulocytes. Peters AM; Roddie ME; Danpure HJ; Osman S; Zacharopoulos GP; George P; Stuttle AW; Lavender JP Nucl Med Commun; 1988 Jun; 9(6):449-63. PubMed ID: 3412733 [TBL] [Abstract][Full Text] [Related]
9. A comparison of three methods to determine the radiochemical purity of 99Tcm-hexamethylpropylene amine oxime (99Tcm-HMPAO). Mah G; Reilly RM; Wong GL; Houle S Nucl Med Commun; 1989 Oct; 10(10):733-40. PubMed ID: 2616098 [TBL] [Abstract][Full Text] [Related]
10. Gallbladder visualization in 99Tcm-HMPAO autologous white cell scintigraphy. Neilly JB; Gray HW Nucl Med Commun; 1996 Mar; 17(3):243-5. PubMed ID: 8692493 [TBL] [Abstract][Full Text] [Related]
11. The development of a clinical protocol for the radiolabelling of mixed leucocytes with 99Tcm-hexamethylpropyleneamine oxime. Danpure HJ; Osman S; Carroll MJ Nucl Med Commun; 1988 Jun; 9(6):465-75. PubMed ID: 3412734 [TBL] [Abstract][Full Text] [Related]
12. Imaging inflammation with 99Tcm HMPAO labelled leucocytes. Reynolds JH; Graham D; Smith FW Clin Radiol; 1990 Sep; 42(3):195-8. PubMed ID: 2208930 [TBL] [Abstract][Full Text] [Related]
13. Imaging infection and inflammation in an African environment: comparison of 99Tcm-HMPAO-labelled leukocytes and 67Ga-citrate. Bester MJ; Van Heerden PD; Klopper JF; Wasserman HJ; Rubow S; de Klerk F Nucl Med Commun; 1995 Jul; 16(7):599-607. PubMed ID: 7478399 [TBL] [Abstract][Full Text] [Related]
14. Diagnostic value of 99Tcm-d,l-HMPAO-labelled leukocyte scintigraphy in the detection of vascular graft infections. Krznaric E; Nevelsteen A; van Hoe L; de Roo M; Schiepers C; Verbruggen A; Mortelmans L Nucl Med Commun; 1994 Dec; 15(12):953-60. PubMed ID: 7715894 [TBL] [Abstract][Full Text] [Related]
15. Stabilization of Tc-99m D,L-HMPAO preparations as a leucocyte labelling agent. Kao CH; Huang WT; Tsai CS Appl Radiat Isot; 1998 Dec; 49(12):1595-8. PubMed ID: 9745694 [TBL] [Abstract][Full Text] [Related]
16. 99Tcm-HMPAO-labelled white blood cell scans to detect acute appendicitis in older patients with an atypical clinical presentation. Lin WY; Kao CH; Lin HT; Wang YL; Wang SJ; Liu TJ Nucl Med Commun; 1997 Jan; 18(1):75-8. PubMed ID: 9061706 [TBL] [Abstract][Full Text] [Related]
17. Is 99Tcm hexamethyl-propyleneamine oxime uptake in the tissues related to glutathione cellular content? el-Shirbiny AM; Sadek S; Owunwanne A; Yacoub T; Suresh L; Abdel-Dayem HM Nucl Med Commun; 1989 Dec; 10(12):905-11. PubMed ID: 2622593 [TBL] [Abstract][Full Text] [Related]
18. 99Tcm hexamethylpropyleneamineoxime (HMPAO) as a platelet label: evaluation of labelling parameters and first in vivo results. Becker W; Börner W; Borst U Nucl Med Commun; 1988 Oct; 9(10):831-42. PubMed ID: 3211441 [TBL] [Abstract][Full Text] [Related]
19. Anaphylactoid reaction associated with the use of 99Tcm hexamethyl propylene amine oxime as a leukocyte labelling agent. Giaffer MH; Tindale WB; Senior S; Holdsworth CD Br J Radiol; 1991 Jul; 64(763):625-6. PubMed ID: 1873662 [No Abstract] [Full Text] [Related]
20. Effects of alternative reconstitution procedures on the labelling efficiency and in vitro stability of 99Tcm-labelled radiopharmaceuticals. Bogsrud TV; Chen MN; Herold TJ; Mahoney DW; Hung JC Nucl Med Commun; 1999 Jan; 20(1):61-5. PubMed ID: 9949414 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]